Levine Leichtman-backed Prime Global Medical Comms adds-on HCD Economics

Levine Leichtman invested in Prime Global through its second Europe fund.

Levine Leichtman Capital Partners-backed Prime Global Medical Communications added-on HCD Economics, which conducts research and collects proprietary health economic evidence for market access, pricing, and reimbursement. Levine Leichtman invested in Prime Global through its second Europe fund.

Press Release

Prime Global Medical Communications Ltd. (“Prime Global” or the “Company”), a portfolio company of Levine Leichtman Capital Partners (“LLCP”), announced today that it has acquired HCD Economics Ltd. (“HCD Economics”). Terms of the transaction were not disclosed.

Prime Global is a global medical communications and market access group that provides the world’s leading biotech, pharmaceutical and healthcare businesses with full-service professional communications, including healthcare strategy and consultancy, scientific and medical communications, consumer health, patient-integrated science, and market access.

Founded in 2013, HCD Economics is an academically backed organization operating in the high-growth health economics and outcomes research (HEOR) and real-world evidence (RWE) space. HCD Economics specializes in conducting burden of disease research and gathering of proprietary health economic evidence needed for market access, pricing, and reimbursement to support pharmaceutical clients across the U.S., U.K. and other key European markets.

Graeme Peterson, Founder and CEO of Prime Global, commented, “Prime Global and HCD Economics are both steadfastly focused on improving patients’ lives, and an excellent strategic fit with one another. Combining HCD’s evidence generation and analytic expertise with our specialist medical, patient, and payer communications skills will strengthen our support to clients, helping ensure patients have timely access to innovative treatments. I am excited for our teams to collaborate and pursue many attractive opportunities as our new partnership unfolds.”

Josh Kaufman, Senior Managing Director at LLCP, added, “We are delighted to support Prime Global in its first acquisition since LLCP’s partnership with Graeme and the management team. HCD Economics is highly complementary to Prime Global’s market access and health economics segment. We look forward to the benefits of this combination and to the continued execution of Prime Global’s ambitious growth plans through further strategic M&A, both in Europe and the U.S.”

Prime Global is a portfolio company of Levine Leichtman Capital Partners Europe II, SCSp.

About Levine Leichtman Capital Partners

Levine Leichtman Capital Partners, LLC is a middle-market private equity firm with a 38-year track record of investing across various targeted sectors, including franchising, business services, education and engineered products. LLCP utilizes a differentiated Structured Private Equity investment strategy, combining debt and equity capital investments in portfolio companies. This unique structure provides a less dilutive solution for management teams and entrepreneurs, while delivering growth and income with a significantly lower risk profile.

LLCP’s global team of dedicated investment professionals is led by nine partners who have worked at LLCP for an average of 18 years. Since inception, LLCP has managed approximately $12.8 billion of institutional capital across 15 investment funds and has invested in over 90 portfolio companies. LLCP currently manages $8.9 billion of assets and has offices in Los Angeles, New York, Chicago, Charlotte, Miami, London, Stockholm, The Hague and Frankfurt.